小柯机器人

Neuropilin-1是T细胞记忆检查点
2020-07-16 15:00

美国匹兹堡大学Dario A. A. Vignali团队的研究发现Neuropilin-1是T细胞记忆检查点,可限制长期抗肿瘤免疫力。这一研究成果于2020年7月13日在线发表在《自然—免疫学》上。

研究人员发现,在具有CD8+T细胞限制的Neuropilin-1(NRP1)缺失小鼠中,尽管原发性肿瘤的生长未发生改变,但对肿瘤再发的保护作用显著增强,并且对抗PD1免疫疗法的敏感性增强。从机制上讲,NRP1从本质上限制了CD44+PD1+TCF1+TIM3-前体耗竭T细胞的自我更新,这与其在T细胞受体再刺激时诱导c-Jun/AP-1表达的能力降低有关。这一机制在野生型荷瘤宿主中可能以记忆分化为代价导致终末T细胞衰竭。
 
这些数据表明,对NRP1的阻断(一种独特的“免疫记忆检查点”)可能促进长期肿瘤特异性Tmem的发育,这对于持久的抗肿瘤免疫至关重要。
 
据悉,强大的CD8+T细胞记忆对于长期的保护性免疫至关重要,但在癌症中通常会受到损害,因为T细胞衰竭会导致记忆前体细胞的丧失。利用检查点抑制的免疫疗法可能无法有效逆转这种缺陷,从而可能导致潜在的疾病复发。
 
附:英文原文

Title: Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity

Author: Chang Liu, Ashwin Somasundaram, Sasikanth Manne, Angela M. Gocher, Andrea L. Szymczak-Workman, Kate M. Vignali, Ellen N. Scott, Daniel P. Normolle, E. John Wherry, Evan J. Lipson, Robert L. Ferris, Tullia C. Bruno, Creg J. Workman, Dario A. A. Vignali

Issue&Volume: 2020-07-13

Abstract: Robust CD8+ T cell memory is essential for long-term protective immunity but is often compromised in cancer, where T cell exhaustion leads to loss of memory precursors. Immunotherapy via checkpoint blockade may not effectively reverse this defect, potentially underlying disease relapse. Here we report that mice with a CD8+ T cell–restricted neuropilin-1 (NRP1) deletion exhibited substantially enhanced protection from tumor rechallenge and sensitivity to anti-PD1 immunotherapy, despite unchanged primary tumor growth. Mechanistically, NRP1 cell-intrinsically limited the self-renewal of the CD44+PD1+TCF1+TIM3 progenitor exhausted T cells, which was associated with their reduced ability to induce c-Jun/AP-1 expression on T cell receptor restimulation, a mechanism that may contribute to terminal T cell exhaustion at the cost of memory differentiation in wild-type tumor-bearing hosts. These data indicate that blockade of NRP1, a unique ‘immune memory checkpoint’, may promote the development of long-lived tumor-specific Tmem that are essential for durable antitumor immunity.

DOI: 10.1038/s41590-020-0733-2

Source: https://www.nature.com/articles/s41590-020-0733-2

Nature Immunology:《自然—免疫学》,创刊于2000年。隶属于施普林格·自然出版集团,最新IF:31.25
官方网址:https://www.nature.com/ni/
投稿链接:https://mts-ni.nature.com/cgi-bin/main.plex


本期文章:《自然—免疫学》:Online/在线发表

分享到:

0